Tmod Cellular Logic Gate As A Solution To On-Target, Off-Tumor Toxicity In Car-T For Solid Tumors

Tmod cellular logic gate as a solution to on-target, off-tumor toxicity in CAR-T for solid tumors

Identifying patients with solid tumors for HLA loss of heterozygosity

CAR-T in solid tumors: challenges and future directions

How can Elicera’s iTANK technology boost CAR-T cell therapies?

Science Animated

Engineering universal chimeric antigen receptors (CARs) for cancer therapy

Activated T cell attacks a cancer cell

Nanolive, Looking inside life

Promoting the functional persistence of CAR-T cells in solid tumors via immune checkpoint blockade

Mechanisms of resistance to CAR-T in ALL: T-cell fitness, antigen loss and immunological rejection

VJHemOnc – Video Journal of Hematology & HemOnc

Mesothelin-specific CAR-T Cell Therapy with HLA-gated Safety Mechanism Selectively Kills Tumor Cells

The Jackson Laboratory

Approach to Immunotherapy Related Toxicity

Label-free Live Cell Imaging: Activated T-Cell Killing Cancer Cell

Nanolive, Looking inside life

Cellular Therapy Including Transgenic T Cell Receptors for Solid Tumors

Chimeric Antigen Receptor T-Cell Therapy, From Approval to Practice, Managing Side Effects

OncBrothers: Practice-Changing Cancer Discussions

MNE108 TestOut 5.4.6 Implement a RAID Solution

Engineering molecular ON- and OFF-switches for controlling CAR T-cells

VJHemOnc – Video Journal of Hematology & HemOnc

ADCLEC.SYN1: combinatorial CAR shows preclinical potential for R/R AML

VJHemOnc – Video Journal of Hematology & HemOnc

T-cell Receptor Repertoire Sequencing - A Missing Piece of the Immuno-oncology puzzle?

Thermo Fisher Scientific

[Holotomography] CAR T-cells attacking a cancer cell

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

TCR Signaling